To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Alpha-mannosidosis: chara… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Alpha-mannosidosis: characterization of CNS pathology and correlation between CNS pathology and cognitive function

Journal article
Authors L. Borgwardt
E. R. Danielsen
C. Thomsen
Jan-Eric Månsson
N. Taouatas
A. M. Thuesen
K. J. Olsen
J. Fogh
C. I. Dali
A. M. Lund
Published in Clinical Genetics
Volume 89
Issue 4
Pages 489-494
ISSN 0009-9163
Publication year 2016
Published at Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine
Pages 489-494
Language en
Links dx.doi.org/10.1111/cge.12642
Keywords alpha-mannosidosis, CNS pathology, CSF-biomarkers, lysosomal storage diseases, MRI, MRS, CEREBROSPINAL-FLUID, NERVOUS-SYSTEM, PROTEIN, CHILDREN, DISEASE, VALUES, CORTEX, CATS, TAU, CSF
Subject categories Neurosciences

Abstract

Alpha-mannosidosis (AM) (OMIM 248500) is a rare lysosomal storage disease. The understanding of the central nervous system (CNS) pathology is limited. This study is the first describing the CNS pathology and the correlation between the CNS pathology and intellectual disabilities in human AM. Thirty-four patients, aged 6-35 years, with AM were included. Data from 13 healthy controls were included in the analysis of the magnetic resonance spectroscopy (MRS). Measurements of CNS neurodegeneration biomarkers in cerebrospinal fluid (CSF), CSF-oligosaccharides, and performance of cerebral magnetic resonance imaging (MRI) and MRS were carried out. On MRI, 5 of 10 patients had occipital white matter (WM) signal abnormalities, and 6 of 10 patients had age-inappropriate myelination. MRS demonstrated significantly elevated mannose complex in gray matter and WM. We found elevated concentrations of tau-protein, glial fibrillary acidic protein and neurofilament light protein in 97 patients, 74% and 41% of CSF samples, respectively. A negative correlation between CSF-biomarkers and cognitive function and CSF-oligosaccharides and cognitive function was found. The combination of MRS/MRI changes, elevated concentrations of CSF-biomarkers and CSF-oligosaccharides suggests gliosis and reduced myelination, as part of the CNS pathology in AM. Our data demonstrate early neuropathological changes, which may be taken into consideration when planning initiation of treatment.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?